Table 2.
Body weight of satellite group rats from control and PHF administered for 28 days and follow up of 14 days.
| Weeks | Sex | Weight in grams |
P Value | |
|---|---|---|---|---|
| Control (No treatment) | PHF (1000 mg/kg body wt) | |||
| Baseline | M (n = 3) | 207.66 ± 18.14 | 205.66 ± 22.94 | |
| F (n = 3) | 208.18 ± 8.18 | 206.30 ± 7.21 | ||
| T (n = 6) | 207.80 ± 12.52 | 205.84 ± 15.24 | P = 0.809 | |
| Week 1 | M (n = 3) | 207.33 ± 14.15 | 209.33 ± 25.32 | |
| F (n = 3) | 213.66 ± 8.08 | 200.33 ± 6.82 | ||
| T (n = 6) | 210.52 ± 10.82 | 204.84 ± 17.30 | P = 0.512 | |
| Week 2 | M (n = 3) | 213.33 ± 11.37 | 206.33 ± 23.02 | |
| F (n = 3) | 213.40 ± 11.15 | 196.22 ± 11.13 | ||
| T (n = 6) | 213.35 ± 10.10 | 201.10 ± 17.10 | P = 0.165 | |
| Week 3 | M (n = 3) | 218.30 ± 11.26 | 199.66 ± 28.29 | |
| F (n = 3) | 225.20 ± 4.58 | 198.10 ± 10.58 | ||
| T (n = 6) | 221.52 ± 8.50 | 198.81 ± 19.10 | P = 0.024∗ | |
| Week 4 | M (n = 3) | 222.12 ± 5.29 | 205.33 ± 19.85 | |
| F (n = 3) | 236.66 ± 2.88 | 198.33 ± 9.71 | ||
| T (n = 6) | 229.30 ± 8.80 | 201.82 ± 14.40 | P = 0.002∗ | |
| Week 5 | M (n = 3) | 224.66 ± 8.08 | 207 ± 13.11 | |
| F (n = 3) | 245.00 ± 8.88 | 201.33 ± 6.35 | ||
| T (n = 6) | 234.80 ± 13.40 | 204.14 ± 9.70 | P = 0.001∗ | |
| Week 6 | M (n = 3) | 223.33 ± 12.58 | 199.33 ± 15.27 | |
| F (n = 3) | 258.33 ± 18.92 | 205.66 ± 4.04 | ||
| T (n = 6) | 240.80 ± 23.90 | 198.52 ± 10 | P = 0.006∗ | |
Values expressed as mean ± SD. Significance with One way ANOVA analysis is evaluated as p ≤ 0.05. Note: F – female, M− male, T – total.